Clinical Trials Browser

Phase 1 × Renal Insufficiency × AZD 6244 × Clear all

NCT02063204 2015-06-30

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

Phase 1 Completed

Renal Insufficiency